Who We Are

Aeris Therapeutics, Inc. is a specialty bio-pharmaceutical company dedicated to the development and commercialization of innovative therapies that improve the lives of patients with lung disease.  We pursue this mission by maintaining our commitment to scientific excellence and the highest quality standards.  Our company possesses a fundamental core clinical competence in pulmonary medicine with substantial internal capabilities in basic sciences, preclinical and clinical research, drug delivery, product development, and regulatory affairs.

Aeris’ research and product development efforts currently encompass the areas of interventional pulmonology and targeted delivery of drugs and biologics.  Aeris’ lead product is the Biologic Lung Volume Reduction (BLVR) System, a non-surgical treatment for patients with advanced heterogeneous emphysema. 

Founded in 2000, Aeris Therapeutics Inc. is privately held, with corporate offices in Woburn, MA.